DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0410174 | Fukuyama Type Congenital Muscular Dystrophy | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C0555198 | Malignant Glioma | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C0026848 | Myopathy | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C0600139 | Prostate carcinoma | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C0003873 | Rheumatoid Arthritis | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C0376358 | Malignant neoplasm of prostate | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C0205944 | Sarcoma, Epithelioid | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C1176475 | Ductal Carcinoma | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C1306459 | Primary malignant neoplasm | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0027651 | Neoplasms | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0006826 | Malignant Neoplasms | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0009402 | Colorectal Carcinoma | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0235974 | Pancreatic carcinoma | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0699790 | Colon Carcinoma | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0376358 | Malignant neoplasm of prostate | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0030297 | Pancreatic Neoplasm | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0032580 | Adenomatous Polyposis Coli | B3GNT6 | 192134 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | Q6ZMB0 |
C0027651 | Neoplasms | SIGLEC15 | 284266 | sialic acid binding Ig like lectin 15 | Q6ZMC9 |
C0029456 | Osteoporosis | SIGLEC15 | 284266 | sialic acid binding Ig like lectin 15 | Q6ZMC9 |
C0006826 | Malignant Neoplasms | SIGLEC15 | 284266 | sialic acid binding Ig like lectin 15 | Q6ZMC9 |
C1306459 | Primary malignant neoplasm | SIGLEC15 | 284266 | sialic acid binding Ig like lectin 15 | Q6ZMC9 |
C0699791 | Stomach Carcinoma | CERS6 | 253782 | ceramide synthase 6 | Q6ZMG9 |
C0007137 | Squamous cell carcinoma | CERS6 | 253782 | ceramide synthase 6 | Q6ZMG9 |
C0678222 | Breast Carcinoma | CERS6 | 253782 | ceramide synthase 6 | Q6ZMG9 |
C1839259 | Bulbo-Spinal Atrophy, X-Linked | CERS6 | 253782 | ceramide synthase 6 | Q6ZMG9 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024